News
Minimal Risks With SBRT in Stage I NSCLC
Researchers explored toxicity and 90-day mortality outcomes in patients who received SBRT.
News
FDA Issues Complete Response Letter for Myeloma Drug
FDA declines to approve linvoseltamab for treatment of relapsed/refractory multiple myeloma, citing issues at a third-party manufacturer.
News
Can ChatGPT Improve Pancreatic Cancer Synoptic Reports?
Researchers investigate whether converting free-text radiology reports into structured reports can benefit surgeons.
News
‘Left in the Dark’: Prior Authorization Erodes Trust, Costs More
The major issue overall is the disconnect between the time spent waiting for prior authorization approvals and the necessity of many treatments....
News
FDA approves first 2 gene-editing therapies for sickle cell
These expensive “milestone treatments” greenlighted by the FDA are the first gene-based therapies for sickle cell disease.
News
‘Infuriating’ prescription denial leaves patient without antiemetics
The patient was experiencing severe side effects from standard chemoradiation with weekly cisplatin.
News
Oncologist to insurer: ‘This denial will not stand’
Exasperated doctor takes insurance coverage dispute to Twitter.
News
Life and death decisions: What keeps oncologists up at night
“It’s part of the discomfort you live with as a patient and oncologist, and when I leave the clinic, that’s one thing that follows me home.”
News
FDA withdraws lymphoma drug approval after investigation
Last February, the FDA said it was investigating a possible increased risk of death associated with umbralisib. Five months later, the results are...
News
Geography hampers access to lung cancer screening
“There are fewer facilities in rural areas, so residents need to travel longer distances to reach a facility.”
News
FDA investigates possible increased risk of death with lymphoma drug
Clinical trial findings of “possible increased risk of death” associated with the drug umbralisib for CLL prompted the FDA to announce...